Nuxe has been acquired by NAXICAP Partners
The shareholders of Nuxe have sold the company to NAXICAP Partners for US$66 million.
Nuxe manufactures natural cosmetics and skin and hair care products and is one of the most dynamic players in the market for natural cosmetics in pharmacies and paraphamacies. The company is headquartered in France and has 260 employees.
NAXICAP Partners is an investment firm specializing in direct and fund of fund investments. It focuses on start-ups, venture capital, growth capital, and middle-market investments, expansion capital, turnarounds, reorganization of capital ownership, funding post early-stage company creations, and buyout transactions such as leveraged buyouts, owner's buyouts, management buyouts, and management buyins. NAXICAP Partners has been a responsible and committed financial partner for companies for over 30 years, has approximately US$600 million of capital under management and is now one of the leading providers of equity financing for businesses in France.
Oaklins' team in France advised the seller in this transaction.
Talk to the deal team
Related deals
EuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Learn moreMEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn more